Skip to main content
From Bio Co., Ltd. logo

From Bio Co., Ltd. — Investor Relations & Filings

Ticker · 377220 ISIN · KR7377220009 KO Manufacturing
Filings indexed 112 across all filing types
Latest filing 2021-12-15 Regulatory Filings
Country KR South Korea
Listing KO 377220

From Bio Co., Ltd. is a healthcare company specializing in the research, development, manufacturing, and sale of health functional foods and dietary supplements. The company operates across the entire value chain, from sourcing new raw materials to production in its GMP-certified facility. A significant focus is placed on research and development through its specialized Food, Bio, and New Drug laboratories. These divisions work on discovering and verifying novel functional ingredients for health foods while also developing new pharmaceuticals, including treatments for alopecia and first-in-class drugs. The product portfolio addresses specific health needs such as joint health (Boswellia), stomach comfort (Mastic Gum), eye health (Bilberry), and body fat reduction (Wild Mango), emphasizing the use of natural, plant-based ingredients.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 90% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action related to shareholder rights. Given the nature of the announcement and its brevity, it fits best under the general regulatory filing category.
2021-12-15 Korean
기타경영사항(특허권취득)(자율공시)(수용화 매스틱 검과 감태나무 추출물을 이용한 발모 촉진 또는 탈모 억제용 조성물)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure (DART filing) from a Korean company regarding the acquisition of a patent. It details the patent name, content, and utilization plan. Since it is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2021-11-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Frombio Co., LTD.' (주)프롬바이오, covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, shareholding information, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
기타경영사항(특허권취득)(자율공시)(천연물 복합 추출물을 함유하는 모발 건강 개선용 식품 또는 화장료 조성물)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company FromBio. It details the patent name, content, and utilization plan. Since it is a specific regulatory announcement regarding corporate developments that does not fit into financial reporting, dividend, or management change categories, it is classified as a general regulatory filing.
2021-10-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This is a standard regulatory filing used by insiders (directors/major shareholders) to disclose their personal share transactions. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2021-10-18 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the company 'FromBio' regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the impact on total shares, and the schedule for new share listing. This type of disclosure regarding capital changes and share issuance falls under the category of share issues or capital changes.
2021-10-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.